Adebrelimab (SHR-1316)

Explore clinical trials studying Adebrelimab (SHR-1316). Study availability and eligibility vary by location and protocol.

5 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Adebrelimab (SHR-1316) trial results

Recruiting

NCT06607276

Conditions: Adebrelimab (SHR-1316), Adenocarcinoma, Carcinoma, +5 more
Locations: Jinling Hospital Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

Yancheng NO.1 People's Hospital Yancheng, Jiangsu, China

Recruiting

NCT06506292

Conditions: Adebrelimab (SHR-1316), GC/GEJC, XELOX
Locations: Tianjin Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

Recruiting

NCT06454448

Conditions: Adebrelimab (SHR-1316), Decitabine, Digestive System Diseases, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

Not Yet Recruiting

NCT07543783

Not Yet Recruiting

NCT07035392